Loading clinical trials...
Loading clinical trials...
GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-01)
Conditions
Interventions
GCAR1
Locations
1
Canada
Tom Baker Cancer Centre/Arthur J.E. Child Comprehensive Cancer Centre
Calgary, Canada
Start Date
September 6, 2023
Primary Completion Date
September 9, 2024
Completion Date
September 9, 2024
Last Updated
July 23, 2025
NCT07548177
NCT06066138
NCT04332874
NCT06813417
NCT06789081
NCT01614795
Lead Sponsor
AHS Cancer Control Alberta
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions